Stellar Cell Bio. was established in 2022, with a dedicated focus on the research, development, and application of cell therapy technologies.
The company holds the largest proprietary clinical cell data repository in Taiwan, which forms the foundation for its “USC” product series. These products are based on patented technology transferred from Dr. Meng-Yin Yang of the Department of Neurosurgery at Taichung Veterans General Hospital. The core active ingredient—exosomes derived from mesenchymal stem cells—has received international INCI certification.

Manufacturing is conducted using TFDA-approved, medical-grade automated equipment, with strict quality control implemented through the 3A-GTP system. All final products undergo independent third-party testing to ensure bioactivity, stability, and compliance with high-end pharmaceutical manufacturing standards.

The “USC” series includes two formulations: USC-E (Essence) and USC-D ( Powder).
USC-D is a high-concentration dry powder produced through a proprietary concentration process, offering a shelf life of up to three years at room temperature. This provides excellent flexibility and convenience for both clinical and home use.

Both formulations contain a high concentration of exosomes and have demonstrated outstanding results in health enhancement and aesthetic skincare. The USC series is widely recognized and well-received in the medical aesthetics market and among consumers worldwide.